HOWL Werewolf Therapeutics, Inc.

P/E --
Forward P/E --
Price/Sales 2.022
Beta 0.287
Div Yield --
Market Cap --

Company Analysis

Latest News

Werewolf Therapeutics to Merge with Ambros Therapeutics, Supported by $150M PIPE Financing

Werewolf Therapeutics, Inc. (HOWL) has entered into a definitive merger agreement with Ambros Therapeutics, Inc. Under the terms of the agreement, Ambros will...